2020
DOI: 10.1016/j.kint.2019.09.020
|View full text |Cite|
|
Sign up to set email alerts
|

Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 8 publications
0
18
0
Order By: Relevance
“…Details of the study design have been previously published. 28 In brief, patients with a clinical diagnosis of type I or type II DM undergoing clinically indicated kidney biopsy were consented for the study. Only participants with central pathology reading consistent with RPS diagnostic criteria for diabetic glomerulosclerosis were followed longitudinally.…”
Section: Study Populationmentioning
confidence: 99%
See 1 more Smart Citation
“…Details of the study design have been previously published. 28 In brief, patients with a clinical diagnosis of type I or type II DM undergoing clinically indicated kidney biopsy were consented for the study. Only participants with central pathology reading consistent with RPS diagnostic criteria for diabetic glomerulosclerosis were followed longitudinally.…”
Section: Study Populationmentioning
confidence: 99%
“…TRIDENT is a multicenter observational cohort aimed to identify changes associated with kidney function decline in patients with DM in an unbiased manner via multi-omics characterization of kidney tissue specimens. 28 In the present study, we analyzed histopathologic features obtained from a comprehensive descriptor-based scoring system, including LM and EM, in a subset of TRIDENT patients to explore the relationship between histopathologic changes, clinical parameters, and outcomes.…”
mentioning
confidence: 99%
“…Data are lacking regarding the feasibility and safety of obtaining research kidney biopsy cores. To address this issue, we present an interim analysis of the Transforming Research in Diabetic Nephropathy (TRIDENT) study (Clinicaltrials.gov identifier: NCT02986984), a multicenter, longitudinal, observational cohort study of adults with diabetes undergoing clinically indicated kidney biopsies and consenting to an additional research biopsy core (1).…”
mentioning
confidence: 99%
“…While structural injury, proteinuria and GFR all correlate with one another, they are not inextricably linked and so likely reflect different pathological processes. The precise molecular pathways that account for these are only starting to be unraveled in detail with the use of next generation sequencing with whole tissue RNASeq, single cell RNASeq and spatial transcriptomics to interrogate human kidney biopsy tissue in large multicentre consortia such as TRIDENT 27 and NIDDK's Kidney Precision Medicine Project.…”
Section: Discussionmentioning
confidence: 99%